Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in Patients With Risk Factors for Severe Acute Postoperative Pain: a Randomized Controlled Trial

NCT07665762 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT07665762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07665762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liposomal Bupivacaine Plus Plain Bupivacaine Versus Dexamethasone Plus Plain Bupivacaine in the Supraclavicular Brachial Plexus Block in Patients With Risk Factors for Severe Acute Postoperative Pain: a Randomized Controlled Trial
Lead sponsor
The University of Hong Kong
Phase
Phase 3
Overall status
Recruiting
Start date
August 4, 2026
Completion date
March 1, 2029
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexamethasone, distal radial fracture, high risk factors, liposomal bupivacaine, pain, postoperative, supraclavicular brachial plexus block